Dr Philippe Beuzeboc
- Spécialité
- Oncologue médical, expert urologie
- Titre
- Chef de département
- Hôpital
- Hôpital Foch (Suresnes)
- Derniers articles
-
- Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial. (19 mai 2025)
- Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients. (9 mai 2025)
- Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary. (1 mars 2025)
- Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer. (30 oct. 2024)
- The genomic and transcriptomic landscape of metastastic urothelial cancer. (4 oct. 2024)